CVI Holdings’s Beam Therapeutics BEAM Stock Holding History

CVI Holdings’s Portfolio BEAM Stock Details BEAM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-268,820	Closed	-$21.5M	–	792
2021 Q1	$21.5M	Buy	+268,820	New	+$25.6M	1.49%	4

Other funds holding BEAM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

MWG Management Road Town, Tortola, British Virgin Islands $81.3M AUM 2.28% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CVI Holdings's BEAM Position: Q2 2021 in Review

CVI Holdings sold out of Beam Therapeutics (BEAM) in Q2 2021, closing a stake of 268,820 shares — an estimated $21.5M sold.

CVI Holdings first reported a position in BEAM in Q1 2021 and held it in 1 quarter. The position peaked at $21.5M in Q1 2021. 231 funds tracked by Wall St. Rank hold BEAM as of Q2 2021.

CVI Holdings reported no remaining Beam Therapeutics position as of Q2 2021 after selling out during the quarter.
CVI Holdings sold 268,820 Beam Therapeutics shares in Q2 2021, an estimated $21.5M.
CVI Holdings first reported a position in Beam Therapeutics in Q1 2021 and held it in 1 quarter.
CVI Holdings's Beam Therapeutics position peaked at $21.5M in Q1 2021.
231 funds tracked by Wall St. Rank held Beam Therapeutics as of Q2 2021.

Based on CVI Holdings's 13F filing for Q2 2021, filed 11 Aug 2021.